MAPLE GROVE, Minn., Aug. 27 (HSMN NewsFeed) — NeuroVasx, Inc., a laboratory device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment …
Devices, Interventional, Neurology, Regulatory
NeuroVasx, cPAX Aneurysm Treatment, embolization, cerebral aneurysm

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “NeuroVasx Receives Canadian Approval for cPAX Aneurysm Treatment System”
Leave a Comment